Option Care Health (OPCH) EBITDA (2009 - 2026)

Option Care Health has reported EBITDA for 18 years, with the latest figure at $44.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 0.6% year-over-year to $44.6 million; the trailing twelve-month figure through Mar 2026 stood at $200.9 million (down 2.42% YoY), and the FY2025 full-year result was $200.6 million, down 3.49% from the prior year.
• EBITDA for Q1 2026 stood at $44.6 million, down from $57.1 million in the prior quarter.
• The five-year high for EBITDA was $117.7 million in Q2 2023, with the low at $35.8 million in Q1 2023.
• Historically, EBITDA has averaged $52.1 million across 5 years, with a median of $48.1 million in 2022.
• Annual changes were most pronounced in 2022 — EBITDA surged 3288.93% — and 2024, when it sank 55.7%.
• Option Care Health's EBITDA stood at $44.2 million in 2022, then advanced by 15.66% to $51.1 million in 2023, then advanced by 20.71% to $61.7 million in 2024, then slipped by 7.41% to $57.1 million in 2025, then declined by 21.88% to $44.6 million in 2026.
• The last three EBITDA figures came in at $44.6 million (Q1 2026), $57.1 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.